Wegovy is a branded, FDA-approved product from a retail pharmacy, while compounded semaglutide is made to prescription through a 503A pharmacy
In December 2024, the FDA hosted a virtual public workshop focusing on PED use in the drug development process, and discussing the methodological challenges of designing and implementing in-trial qualitative interviews [7, 8]
Lilly has also confirmed that orforglipron is being studied for weight-related conditions such as obstructive sleep apnea (OSA) and high blood pressure (hypertension) in adults with a BMI of 27 or higher
without a clear record, it's difficult to know if they're improving or if you've just become used to feeling unwell
These medications are intended for people with obesity or those who are overweight with related health issues
Many patients experience consistent progress with semaglutide treatments, especially when paired with lifestyle support